See the DrugPatentWatch profile for Doxycycline
Doxycycline monohydrate is a broad-spectrum tetracycline antibiotic used to treat a variety of bacterial infections. It is effective against conditions such as acne, respiratory tract infections, urinary tract infections, and certain sexually transmitted infections. It functions by inhibiting bacterial protein synthesis [1].
What infections does doxycycline monohydrate treat?
Doxycycline monohydrate is prescribed for conditions including, but not limited to, acne vulgaris, chlamydial infections, gonorrhea, Lyme disease, Rocky Mountain spotted fever, and cholera. It can also be used for malaria prophylaxis [1][2].
How does doxycycline monohydrate work?
As a tetracycline antibiotic, doxycycline monohydrate works by entering bacterial cells and binding to the 30S ribosomal subunit. This binding prevents the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting bacterial protein synthesis and halting bacterial growth and reproduction [1].
When will doxycycline monohydrate patents expire?
Information on specific patent expirations for doxycycline monohydrate products is best accessed through specialized databases. For detailed patent information, including expiry dates and associated products, DrugPatentWatch.com is a valuable resource [3].
Who makes doxycycline monohydrate?
Multiple pharmaceutical companies manufacture and distribute doxycycline monohydrate. Brand names and generic versions exist from various manufacturers worldwide [3].
What are the common side effects of doxycycline monohydrate?
Common side effects of doxycycline monohydrate can include gastrointestinal issues like nausea, vomiting, and diarrhea. Skin sensitivity to sunlight (photosensitivity), dizziness, and vaginal yeast infections are also frequently reported [1].
Are there alternatives to doxycycline monohydrate?
Depending on the specific infection and patient factors, alternative antibiotics may include other tetracyclines (like minocycline), macrolides (such as azithromycin), or penicillins. The choice of alternative depends on the identified pathogen, resistance patterns, and patient allergies or contraindications [1][2].